Literature DB >> 20980431

Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components.

Sheena Kayaniyil1, Reinhold Vieth, Stewart B Harris, Ravi Retnakaran, Julia A Knight, Hertzel C Gerstein, Bruce A Perkins, Bernard Zinman, Anthony J Hanley.   

Abstract

CONTEXT: Emerging evidence suggests that 25-hydroxy vitamin D [25(OH)D] and PTH may play a role in the etiology of the metabolic syndrome (MetS). However, evidence to date is limited and inconsistent, and few studies have examined associations with nontraditional MetS components.
OBJECTIVE: The objective of the study was to examine the association of vitamin D and PTH with MetS and its traditional and nontraditional components in a large multiethnic sample. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, we examined 654 participants from London and Toronto, Ontario, Canada, aged 30 yr and older with risk factors for type 2 diabetes. MAIN OUTCOME MEASURES: Presence of MetS and its traditional and nontraditional components was measured.
RESULTS: Approximately 43% of the study participants were classified as having MetS. Higher 25(OH)D was significantly associated with a reduced presence of MetS after adjustment for age, sex, season, ethnicity, supplement use, physical activity, and PTH (odds ratio 0.76, 95% confidence interval 0.62-0.93). PTH was not associated with the presence of MetS after multivariate adjustment. Multivariate linear regression analyses indicated significant adjusted inverse associations of 25(OH)D with waist circumference, triglyceride level, fasting insulin, and alanine transaminase (P < 0.041). Elevated PTH was positively associated with waist circumference and high-density lipoprotein cholesterol (P < 0.04). Other associations between PTH and MetS components were attenuated after adjustment for adiposity.
CONCLUSIONS: Serum 25(OH)D, but not PTH, was significantly associated with MetS as well as a number of MetS components after multivariate adjustment. These results suggest that low 25(OH)D may play a role in the etiology of the MetS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980431     DOI: 10.1210/jc.2010-1439

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

1.  Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20 y: the Coronary Artery Risk Development in Young Adults study.

Authors:  Grace J Fung; Lyn M Steffen; Xia Zhou; Lisa Harnack; Weihong Tang; Pamela L Lutsey; Catherine M Loria; Jared P Reis; Linda V Van Horn
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

2.  Relations between obesity, insulin resistance, and 25-hydroxyvitamin D.

Authors:  Cynthia A Lamendola; Danit Ariel; David Feldman; Gerald M Reaven
Journal:  Am J Clin Nutr       Date:  2012-03-21       Impact factor: 7.045

Review 3.  Management of fat accumulation in patients with HIV infection.

Authors:  Julian Falutz
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

4.  Plasma vitamin D is associated with fasting insulin and homeostatic model assessment of insulin resistance in young adult males, but not females, of the Jerusalem Perinatal Study.

Authors:  Amy Moore; Hagit Hochner; Colleen M Sitlani; Michelle A Williams; Andrew N Hoofnagle; Ian H de Boer; Bryan Kestenbaum; David S Siscovick; Yechiel Friedlander; Daniel A Enquobahrie
Journal:  Public Health Nutr       Date:  2014-08-22       Impact factor: 4.022

5.  Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program.

Authors:  J Mitri; J Nelson; R Ruthazer; C Garganta; D M Nathan; F B Hu; B Dawson-Hughes; A G Pittas
Journal:  Eur J Clin Nutr       Date:  2014-01-22       Impact factor: 4.016

6.  TSH levels are associated with vitamin D status and seasonality in an adult population of euthyroid adults.

Authors:  I Barchetta; M G Baroni; F Leonetti; M De Bernardinis; L Bertoccini; M Fontana; E Mazzei; A Fraioli; M G Cavallo
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

7.  25(OH)D3 and cardiovascular risk factors in female nonhuman primates.

Authors:  Matthew J Jorgensen; Lawrence L Rudel; Matthew Nudy; Jay R Kaplan; Thomas B Clarkson; Nicholas M Pajewski; Peter F Schnatz
Journal:  J Womens Health (Larchmt)       Date:  2012-08-09       Impact factor: 2.681

8.  Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese.

Authors:  Li-Hua Li; Xue-Yan Yin; Chao-Yong Yao; Xue-Chuang Zhu; Xin-Hua Wu
Journal:  Endocrine       Date:  2013-01-23       Impact factor: 3.633

9.  Effect of long term vitamin D supplementation on biomarkers of inflammation in Latino and African-American subjects with pre-diabetes and hypovitaminosis D.

Authors:  I Sinha-Hikim; P Duran; R Shen; M Lee; T C Friedman; M B Davidson
Journal:  Horm Metab Res       Date:  2014-07-10       Impact factor: 2.936

10.  Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional study.

Authors:  Jie Dong; Qin Wang; Meng-Hua Chen; Hui-Ping Zhao; Tong-Ying Zhu; Na Tian; Mei Wang; Chuan-Ming Hao; Ye-Ping Ren; Hai-Yan Wang
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.